Neurol. pro Praxi, 2004; 5: 268-270

Nesteroidní analgetika

prof. MUDr. Oto Masár, CSc

Keywords: neuropatická bolest, analgeze, nesteroidní analgetika, inhibice cyoklooxygenázy, gastrointestinální komplikace.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Masár O, CSc. Nesteroidní analgetika. Neurol. praxi. 2004;7(5):268-270.

prof. MUDr. Oto Masár, CSc.

Klinika anesteziológie a intenzívnej medicíny, Univerzita Konštantína Filozofa a FN, Nitra

Autor pojednává o účincích nesteroidních antirevmatik (NSA) v léčbě neuropatické bolesti, podrobně jsou rozebrány jejich indikace, ale i jejich vedlejší účinky.

Na základě dostupné literatury je možné doporučit, že při akutní bolesti je nejdůležitějším požadavkem analgetický účinek a při respektování kontraindikací se nemusíme orientovat na selektivitu enzymu COX-2. U chronické bolesti je kvůli uvedeným možným účinkům vhodné u pacientů dlouhodobě léčených NSA využívat léky s vyšší selektivitou k enzymu COX-2.

Download citation

References

  1. Ambler Z. Neuropatická bolest a současné možnosti její farmakologické léčby. Bolest 2000; 3: 17-21.
  2. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998; 280: 1831-1836. Go to original source... Go to PubMed...
  3. Bakoš E. Chirurgia, UKF Nitra, 2004: 22-26.
  4. Boivie J. Central pain syndromes. In Pain 1996. An updated review. Ed JN Campbell. Seattle: IASP Press, 1996: 23-29.
  5. Bonica JJ. Introduction: semantic, epidemiologic, and educational issues. In: Pain and central nervous system disease: The central pain syndromes, Casey KL (ed). New York: Raven Press, 1991: 13-29.
  6. Casey KL. Central pain: an update. Syllabi on CD-Rom. 49th AAN Annual Meeting, Boston, 1997.
  7. Classification of chronic pain, 2nd Edition, IASP task force on taxonomy. Merskey H, Bogduk N eds., Seattle: IASP Press, 1994: 209-214.
  8. CONTINUUM - Pain. American Academy of Neurology, Minneapolis, USA, 1996; 2: 115.
  9. Farrar JT. Therapeutic use of adjuvant analgesics: antidepressants, anticonvulsants, and miscellaneous agents. Syllabi on CD-Rom. 51st AAN Annual Meeting, Toronto, 1999.
  10. Galer BS. Treatment of neuropathic pain: use of, ,adjuvant" analgesics. Syllabi on CD-Rom. 49th AAN Annual Meeting, Boston, 1997.
  11. Gorson KC, Ropper AH. Idiopathic distal small fiber neuropathy. Acta Neurol Scand 1995; 92: 376-382. Go to original source... Go to PubMed...
  12. Grond S, Radbruch L, Meuser T, Sabatowski R, Loick G, Lehmann KA. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain 1999; 79: 15-20. Go to original source... Go to PubMed...
  13. Hansson P. Neurogenic pain: diagnosis and treatment. Pain. Clinical updates, 1994; 2: 18.
  14. Koltzenburg M. Painful neuropathies. Curr Opin Neurol 1998; 11: 515-521. Go to original source... Go to PubMed...
  15. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA: A systematic review of antidepressants in neuropathic pain. Pain 68, 1996: 217-227. Go to original source... Go to PubMed...
  16. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch internal med 1999; 159: 1931-1937. Go to original source... Go to PubMed...
  17. Opavský J. Terminologie bolesti. Bolest 1998; 1: 4-7.
  18. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999; 83: 389-400. Go to original source... Go to PubMed...
  19. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial. JAMA 1998; 280: 1837-1842. Go to original source... Go to PubMed...
  20. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-1964. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.